Parma, Italy

Anna Rencurosi


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anna Rencurosi: Innovator in Pharmaceutical Compounds

Introduction

Anna Rencurosi is a notable inventor based in Parma, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and antiallergic compounds. Her work focuses on innovative treatments for respiratory conditions, showcasing her dedication to improving patient care.

Latest Patents

Anna Rencurosi holds a patent for pyrrolidine compounds and pharmaceutical compositions that contain these compounds. The patent, titled "Pyrrolidine compounds, pharmaceutical compositions containing the same, devices containing the same, and methods of treating asthma or chronic obstructive pulmonary disease by administering the same," highlights her invention of novel glucocorticosteroid derivatives. These compounds are designed to provide therapeutic benefits for individuals suffering from asthma and chronic obstructive pulmonary disease.

Career Highlights

Throughout her career, Anna has been associated with Chiesi Farmaceutici S.p.a., a prominent pharmaceutical company. Her role at Chiesi has allowed her to collaborate with other talented professionals in the industry, further enhancing her expertise and contributions to pharmaceutical innovations.

Collaborations

Anna Rencurosi has worked alongside notable colleagues such as Eleonora Ghidini and Andrea Rizzi. Their collaborative efforts have played a crucial role in advancing research and development within the pharmaceutical sector.

Conclusion

Anna Rencurosi's innovative work in the field of pharmaceuticals exemplifies her commitment to developing effective treatments for respiratory diseases. Her contributions, particularly through her patent on pyrrolidine compounds, highlight the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…